Form D · Biotechnology

International Stem Cell CORP

Carlsbad, CA · CIK 0001355790

Offering snapshot reported Oct 23, 2014 · SEC filing

Reported sold
$2.5M
Offering amount: $2.5M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 14, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 23, 2014Initial$2,500,000No comparison4SEC filing
Mar 20, 2012Initial$5,000,000No comparison1SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$200K (estimated)
Form D file number
021-227037

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
H.C.Wainwright and Co. LLC375

Source: Form D, filed Oct 23, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sofya Bakalova Executive
James Berglund Director
Charles J. Casamento Director, Executive
Simon Craw Executive
Paul Maier Director
Kurt May Executive
Linh Nguyen Executive
Jay Novak Executive
Ruslan Semechkin Director, Executive
Andrey Semechkin Director, Executive
Donald Wright Director
Don Wright Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5950 Priestly Drive
Carlsbad, CA, 92008